Ishita Drugs & Industries Ltd — Quarterly Results & Earnings

₹69.11

-11.27%

Profit Growth YoY-26.32%Latest quarter

Sales Growth YoY-6.12%Latest quarter

Sales CAGR 5Y0.23%5 year compound

Profit CAGR 5Y9.61%5 year compound

📋

Quarterly Performance

YoY Profit Growth-26.32%

🔴 Significant decline

YoY Sales Growth-6.12%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

6.63%

EPS Growth 5Y

9.61%

Interest Coverage

Higher = safer debt servicing

17.25

ROE

8.40%

ROCE

9.91%

💡

Growth Analysis

Ishita Drugs & Industries Ltd reported YoY profit growth of -26.32% and revenue growth of -6.12% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 0.23% and profits at 9.61% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Ishita Drugs & Industries Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.